Comparison of 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias
G Mombelli, A Roux, A Haeberli, PW Straub - 1982 - ashpublications.org
To provide more information on the pathways of fibrinogen catabolism in generalized
cancer, the effect of heparin on fibrinopeptide A (fpA) and on 125I-fibrinogen kinetics was …
cancer, the effect of heparin on fibrinopeptide A (fpA) and on 125I-fibrinogen kinetics was …
Significance of plasma fibrinopeptide A (fpA) in patients with malignancy
FW Peuscher, FJ Cleton, L Armstrong… - The Journal of …, 1980 - translationalres.com
In 124 patients with various types of malignancy, fpA and ΔfpA were measured. In 35 of
these patients the effect of heparin injection on fpA and ΔfpA was studied. All patients were …
these patients the effect of heparin injection on fpA and ΔfpA was studied. All patients were …
Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease
Y Yoda, T Abe - Thrombosis and Haemostasis, 1981 - thieme-connect.com
FPA level, fibrinogen turnover rate, and fibrinolytic activity were studied on 18 patients with
malignant disease. It was found that the FPA levels were significantly elevated and were …
malignant disease. It was found that the FPA levels were significantly elevated and were …
Abnormalities of blood coagulation in patients with cancer: fibrinopeptide A generation and tumor growth
FR Rickles, RL Edwards, C Barb, M Cronlund - Cancer, 1983 - Wiley Online Library
Fibrinopeptide A (FPA) levels have been followed sequentially in a three‐year study of 50
patients with advanced carcinoma. Evidence for activation of blood coagulation was found in …
patients with advanced carcinoma. Evidence for activation of blood coagulation was found in …
Fibrinogen and fibrinogen-related peptides in cancer
JJ Franks, RE Kirsch, B Kao, TM Kloppel - Pathophysiology of plasma …, 1984 - Springer
Abstract At a previous International Symposium on Plasma Protein Metabolism 1 we
presented evidence that patients with advanced carcinomas of the lung, pancreas and liver …
presented evidence that patients with advanced carcinomas of the lung, pancreas and liver …
Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures
I Lipinska, B Lipinski, V Gurewich… - American Journal of …, 1976 - academic.oup.com
Abstract Electrophoresis in 3.5% polyacrylamide gel was used to determine the patterns of
fibrinogen heterogeneity in healthy subjects, in postoperative patients and in patients with …
fibrinogen heterogeneity in healthy subjects, in postoperative patients and in patients with …
Coagulation disturbances in cancer of the breast and colon measured with specific monoclonal antibody enzyme immunoassay for fibrin-fibrinogen degradation …
P McCulloch, W Nieuwenhuizen, J Douglas… - … of Haemostasis and …, 1990 - karger.com
Disturbances of coagulation were measured in breast cancer, colon cancer and benign
breast disease using an enzyme immunoassay against total plasma fibrinogen and fibrin …
breast disease using an enzyme immunoassay against total plasma fibrinogen and fibrin …
Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis
C Gerner, W Steinkellner, K Holzmann… - Thrombosis and …, 2001 - thieme-connect.com
Cancer-related fibrin deposition and fibrinolysis were investigated by two-dimensional gel
electrophoresis of human solid tumor and effusion specimen in addition to plasma samples …
electrophoresis of human solid tumor and effusion specimen in addition to plasma samples …
Coagulation and cancer.
JC Murray - British journal of cancer, 1991 - ncbi.nlm.nih.gov
As solid tumours rely upon the bloodstream to deliver nutrients necessary for growth, it
follows that interference with that supply may compromise tumour growth. Indeed, this …
follows that interference with that supply may compromise tumour growth. Indeed, this …
Fibrinogen kinetics in patients with neoplastic disease
GH Lyman, RE Bettigole, E Robson, JL Ambrus… - Cancer, 1978 - Wiley Online Library
Fibrinogen half‐life was determined in 30 patients with active or inactive malignancies by
monitoring survival of administered 125I‐labeled autologous fibrinogen. Six patients had no …
monitoring survival of administered 125I‐labeled autologous fibrinogen. Six patients had no …
相关搜索
- disseminated neoplasias fibrinopeptide a in patients
- disseminated neoplasias 125i fibrinogen
- fibrinopeptide a in patients 125i fibrinogen
- fibrin fibrinogen coagulation disturbances
- patients with malignancy plasma fibrinopeptide
- fibrin fibrinogen cancer of the breast
- fibrinogen kinetics malignant disease
- fibrin fibrinogen degradation products
- fibrin fibrinogen breast and colon